Omeprazole affects neither electroconvulsive threshold nor anticonvulsant activity of diphenylhydantoin and carbamazepine in mice

Pharmacological Reports

Volumn 57, Issue 4, 2005, Pages 536-539

  Świader, Mariusz J ^a   Łuszczki, Jarogniew J ^a   Pilip, Sławomir ^a   Kozicka, Maria ^a   Parada Turska, Jolanta ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Cabamazepine; Diphenylhydantoin; Maximal electroshock induced seizures; Omeprazole

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CARBAMAZEPINE; CARBONATE DEHYDRATASE; OMEPRAZOLE; PHENYTOIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ELECTRIC CURRENT; ELECTRIC SHOCK; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; SEIZURE; SEIZURE THRESHOLD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24744471005     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Balakrishnan S, Bhargava VK, Pandhi P: Anticonvulsant activity of omeprazole in rats. Epilepsy Res, 2001, 46, 85-89.
2. Czuczwar SJ, Kleinrok Z, Turski L, Turski WA: Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia, 1987, 28, 383-386.
3. Devinsky O: Patients with refractory seizures. N Engl J Med, 1999, 340, 1565-1570.
4. Konturek SJ, Brzozowski T, Radecki T: Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion, 1983, 27, 159-164.
5. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
6. Okabe S, Akimoto Y, Yamasaki S, Nagai H: Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats. Dig Dis Sci, 1988, 33, 1425-1434.
7. Puscas I, Coltau M, Baican M, Domuta G: Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments). J Pharmacol Exp Ther, 1999, 290, 530-534.
8. Resor SR Jr., Resor LD: Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology, 1990, 40, 1677-1681.
9. Sato J, Nioka M, Owada E, Ito K, Murata T: Effect of acetazolamide on the anticonvulsant potency of several antiepileptic drugs in mice. J Pharmacobiodyn, 1983, 6, 295-300.
10. Watanabe K, Furuno K, Eto K, Oishi R, Gomita Y: First-pass metabolism of omeprazole in rats. J Pharm Sci, 1994, 83, 1131-1134.